Clinical Trials Directory

Trials / Sponsors / Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Industry · 13 registered clinical trials — 11 currently recruiting.

StatusTrialPhaseStarted
RecruitingClinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Phase 22026-03-19
Not Yet RecruitingClinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Comb
Adenocarcinoma
Phase 32026-03-01
RecruitingAssessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain A
Systemic Light Chain Amyloidosis
Phase 1 / Phase 22025-12-26
RecruitingClinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
Advanced Cancers
Phase 12025-12-16
RecruitingClinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combine
Metastatic Pancreatic Ductal Adenocarcinoma
Phase 32025-12-02
Not Yet RecruitingEvaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recur
Follicular Lymphoma
Phase 32025-11-01
RecruitingClinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Phase 32025-09-25
Not Yet RecruitingPhase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
CD20-positive Hematological Malignancies
Phase 12025-09-01
RecruitingTQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Asthma
Phase 32025-03-21
RecruitingClinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
Diffuse Large Cell B-lymphoma
Phase 22025-03-12
CompletedClinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Phase 22025-03-10
Active Not RecruitingA Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Diseas
Chronic Obstructive Pulmonary Disease
Phase 22024-12-31
Not Yet RecruitingTo Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic De
Atopic Dermatitis
Phase 32024-09-01